{
  "compound": "Nabilone (oral)",
  "condition": "GLAUCOMA",
  "effect_size": "Large, equivalent to standard therapy",
  "study_type": "RCT",
  "source": "NORML:GLAUCOMA_RCT_003",
  "participants": "18 patients with ocular hypertension",
  "year": 1980,
  "notes": "Nabilone vs Timolol for Ocular Hypertension: Comparative Trial",
  "confidence": "medium",
  "abstract": "Nabilone: 26% IOP reduction; Timolol: 27% IOP reduction; Non-inferior; Both clinically effective"
}